Hilmiye Nesrin Dilbaz

Prof. Dr. Hilmiye Nesrin Dilbaz

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 July 2022 in The World Journal of Biological Psychiatry
Verified
Journal Article
Closed access
BBBorwin Bandelow
Borwin Bandelow
CAChrister Allgulander
Christer Allgulander
DBDavid S. Baldwin
David S. Baldwin
DCDaniel Lucas da Conceição Costa
Daniel Lucas da Conceição Costa
DDDamiaan Denys
Damiaan Denys
JZJoseph Zohar
Joseph Zohar
This is the third version of the guideline of the World Federation of Societies of Biological Psychiatry (WFSBP) Task Force for the Pharmacological Treatment of Anxiety, Obsessive–Compulsive and Po...


28 July 2022 in The World Journal of Biological Psychiatry
Verified
Journal Article
Closed access
BBBorwin Bandelow
Borwin Bandelow
CAChrister Allgulander
Christer Allgulander
DBDavid S. Baldwin
David S. Baldwin
DCDaniel Lucas da Conceição Costa
Daniel Lucas da Conceição Costa
DDDamiaan Denys
Damiaan Denys
JZJoseph Zohar
Joseph Zohar
Aim: This is the third version of the guideline of the World Federation of Societies of Biological Psychiatry (WFSBP) Task Force for the Pharmacological Treatment of Anxiety, Obsessive–Compulsive and Posttraumatic Stress Disorders which was published in 2002 and revised in 2008. Method: A consensus panel of 34 international experts representing 22 countries developed recommendations based on efficacy and acceptability of the treatments. In this version, not only medications but also psychotherapies and other non-pharmacological interventions were evaluated, applying the same rigorous methods that are standard for the assessment of medication treatments. Result: The present paper (Part II) contains recommendations based on published randomised controlled trials (RCTs) for the treatment of OCD (n = 291) and PTSD (n = 234) in children, adolescents, and adults. The accompanying paper (Part I) contains the recommendations for the treatment of anxiety disorders. For OCD, first-line treatments are selective serotonin reuptake inhibitors (SSRIs) and cognitive behavioural therapy (CBT). Internet-CBT was also superior to active controls. Several second-line medications are available, including clomipramine. For treatment-resistant cases, several options are available, including augmentation of SSRI treatment with antipsychotics and other drugs. Other non-pharmacological treatments, including repetitive transcranial magnetic stimulation (rTMS), deep brain stimulation (DBS) and others were also evaluated. For PTSD, SSRIs and the SNRI venlafaxine are first-line treatments. CBT is the psychotherapy modality with the best body of evidence. For treatment-unresponsive patients, augmentation of SSRI treatment with antipsychotics may be an option. Conclusion: OCD and PTSD can be effectively treated with CBT and medications.

19 October 2020 in Perspectives in Psychiatric Care
Verified
Journal Article
Open access
PDF file
OKOzlem Kazan Kızılkurt
Ozlem Kazan Kızılkurt
AYAhmet Yılmaz
Ahmet Yılmaz
CNCemal Onur Noyan
Cemal Onur Noyan
HDHilmiye Nesrin Dilbaz
Hilmiye Nesrin Dilbaz
Purpose To investigate health anxiety‐related factors in the early stages of pandemic in Turkey. Design and Methods This study included 1046 participants who responded to the online survey anonymously between 28 March and 04 April 2020. Findings Demographic data, postpandemic attitudes towards the elderly and precaution‐taking behaviors were health anxiety‐related factors. The main predictors of the health anxiety were the level of hopelessness, perception of self, time spent on social media, and following COVID‐19 pandemic‐related news. Practice Implications The results of this study are important in terms of understanding the health anxiety during the pandemic and providing data support for the proper interventions.

28 December 2022 in Journal of Affective Disorders
Verified
Journal Article
Closed access
MSMarco Solm
Marco Solm
TTTrevor Thompson
Trevor Thompson
AEAndrés Estradé
Andrés Estradé
Agorastos AgorastosAgorastos Agorastos
Agorastos Agorastos
Joaquim RaduàJoaquim Raduà
Joaquim Raduà
CCChristoph Correll
Christoph Correll

22 November 2024 in Journal of the American Academy of Child & Adolescent Psychiatry
Verified
Journal Article
Open access
MSMarco Solm
Marco Solm
TTTrevor Thompson
Trevor Thompson
SCSamuele Cortese
Samuele Cortese
AEAndrés Estradé
Andrés Estradé
Agorastos AgorastosAgorastos Agorastos
Agorastos Agorastos
CCChristoph Correll
Christoph Correll
To identify the COVID-19 pandemic impact on well-being/mental health, coping strategies, and risk factors in adolescents worldwide. This study was based on an anonymous online multi-national/multi-language survey in the general population (representative/weighted non-representative samples, 14-17 years of age), measuring change in well-being (World Health Organization-Five Well-Being Index [WHO-5]/range = 0-100) and psychopathology (validated composite P-score/range = 0-100), WHO-5 <50 and <29, pre- vs during COVID-19 pandemic (April 26, 2020-June 26, 2022). Coping strategies and 9 a priori- defined individual/cumulative risk factors were measured. A χ2, penalized cubic splines, linear regression, and correlation analyses were conducted. Analyzing 8,115 of 8,762 initiated surveys (representative = 75.1%), the pre-pandemic WHO-5 and P-score remained stable during the study (excluding relevant recall bias/drift), but worsened during the pandemic by 5.55 ± 17.13 (SD) and 6.74 ± 16.06 points, respectively (effect size d = 0.27 and d = 0.28). The proportion of adolescents with WHO-5 scores suggesting depression screening (<50) and major depression (2 years. The 3 most subjectively effective coping strategies were Internet use, exercise/walking, and social contacts. Overall, well-being/mental health worsened (small effect sizes) during the early stages of the COVID-19 pandemic, especially in vulnerable subpopulations. Identified at-risk groups, association with pandemic-related measures, and coping strategies can inform individual behaviors and global public health strategies. The impact of COVID-19 and related restrictions on the mental health of children and adolescents remains unclear. This study conducted an anonymous online survey with over 8,100 adolescents aged 14 to 17 years worldwide. Results showed a significant decline in wellbeing, with depression rates increasing from 9% to 17% returning to near- pre-pandemic values after about 2 years. Adolescents with preexisting mental health conditions, female youth, and those affected by school closures were particularly vulnerable. Effective coping strategies included internet use, exercise, and social contacts, highlighting areas for public health focus to support youth during pandemics. Physical and mental health impact of COVID-19 on children, adolescents, and their families: The Collaborative Outcomes study on Health and Functioning during Infection Times - Children and Adolescents (COH-FIT-C&A); https://doi.org/10.1016/j.jad.2021.09.090 DIVERSITY & INCLUSION STATEMENT: We worked to ensure sex and gender balance in the recruitment of human participants. We worked to ensure race, ethnic, and/or other types of diversity in the recruitment of human participants. We worked to ensure that the study questionnaires were prepared in an inclusive way. The author list of this paper includes contributors from the location and/or community where the research was conducted who participated in the data collection, design, analysis, and/or interpretation of the work. We actively worked to promote inclusion of historically underrepresented racial and/or ethnic groups in science in our author group. We actively worked to promote sex and gender balance in our author group. One or more of the authors of this paper self-identifies as a member of one or more historically underrepresented racial and/or ethnic groups in science.